Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status

NCT05409417 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Liver Metastases

Interventions

DRUG: Experimental drug

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University